Health&Beauty- Page 90

The FINANCIAL -- More than 230,000 men will be diagnosed with prostate cancer this year in the United States, but determining their course of treatment remains a source of considerable debate, according to a new study by researchers from Uppsala University Hospital,

The FINANCIAL -- Previously unaffected areas of Africa, Asia, and South America could be at risk from malaria as the infection moves into upland areas by the end of the century, a University of Liverpool study has shown.

The FINANCIAL -- Among a large group of Midwestern firefighters, greater adherence to a Mediterranean-style diet was associated with lower risk factors for cardiovascular disease (CVD), according to a new study led by researchers from Harvard School of Public Health (HSPH) and

The FINANCIAL -- GE Healthcare is highlighting its path-breaking blood pressure cuff for the forearm, which is envisaged to address inaccurate blood pressure readings for people with large or highly muscular arms, at Arab Health 2014, the Middle East and Africa’s premier

The FINANCIAL -- Diabetes patients under the care of patient navigators were able to decrease abnormal blood glucose levels (HbA1c) and increase the completion of self-measured metrics, such as monitoring blood pressure, on a regular basis, according to Accenture.

The FINANCIAL -- As the global population continues to rise and arable land becomes scarcer, global food security faces a tough challenge. According to the forecast of the Food and Agriculture Organization of the United Nations (FAO), food production needs to increase

The FINANCIAL -- As the year winds down, many people are looking ahead to taking a vacation or visiting friends and relatives, leaving their homes empty, according to Bayer AG.

The FINANCIAL -- Boston, MA – The healthiest diets cost about $1.50 more per day than the least healthy diets, according to new research from Harvard School of Public Health (HSPH).

The FINANCIAL -- Boston, MA — Obesity is associated with a worse prostate cancer prognosis among men whose tumors contain a specific genetic mutation, suggest results from a new study led by Harvard School of Public Health (HSPH), Dana-Farber Cancer Institute and

The FINANCIAL -- Pfizer Inc. has entered into an agreement with GSK to explore the anti-cancer efficacy and the safety of GSK’s trametinib (GSK1120212) combined with Pfizer’s palbociclib (PD-0332991) in a Phase I/II study (Study 200344) in patients with advanced/metastatic melanoma, according